FOXM1D potentiates PKM2‐mediated tumor glycolysis and angiogenesis

Wei Zhang,Xin Zhang,Sheng Huang,Jianfeng Chen,Peipei Ding,Qi Wang,Luying Li,Xinyue Lv,Ling Li,Pingzhao Zhang,Danlei Zhou,Wenyu Wen,Yiping Wang,Qun‐Ying Lei,Jiong Wu,Weiguo Hu

DOI: https://doi.org/10.1002/1878-0261.12879

2021-04-02

Molecular Oncology

Abstract:<p>Tumor growth, especially in the late stage, requires adequate nutrients and rich vasculature, in which PKM2 plays a convergent role. It has been reported that PKM2, together with FOXM1D, is upregulated in late stage colorectal cancer and associated with metastasis; however, their underlying mechanism for promoting tumor progression remains elusive. Herein, we revealed that FOXM1D potentiates PKM2‐mediated glycolysis and angiogenesis through multiple protein‐protein interactions. In the presence of FBP, FOXM1D binds to tetrameric PKM2 and assembles a heterooctamer, restraining PKM2 metabolic activity by about a half and thereby promoting aerobic glycolysis. Furthermore, FOXM1D interacts with PKM2 and NF‐κB and induces their nuclear translocation with the assistance of the nuclear transporter importin 4. Once in the nucleus, PKM2 and NF‐κB complexes subsequently augment <i>VEGFA</i> transcription. The increased VEGFA is secreted extracellularly via exosomes, an event potentiated by the interaction of FOXM1 with VPS11, eventually promoting tumor angiogenesis. Based on these findings, our study provides another insight into the role of PKM2 in the regulation of glycolysis and angiogenesis.</p>

oncology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is how FOXM1D promotes tumor glycolysis and angiogenesis by interacting with PKM2 in advanced colorectal cancer. Specifically, the researchers found that FOXM1D can bind to PKM2 to form a hetero - octamer complex, and this complex inhibits the metabolic activity of PKM2, thereby promoting aerobic glycolysis. In addition, FOXM1D can also promote the nuclear translocation of PKM2 and NF - κB, enhance the transcription of VEGFA, and then secrete VEGFA through exosomes to promote tumor angiogenesis. These findings provide a new perspective for understanding the regulatory mechanism of PKM2 in glycolysis and angiogenesis.

### Main research contents
1. **Interaction between FOXM1D and PKM2**:
- The researchers confirmed the interaction between FOXM1D and PKM2 through co - immunoprecipitation (Co - IP) and GST - pulldown experiments.
- Further experiments showed that FOXM1D mainly binds to PKM2 through its B domain.

2. **FOXM1D promotes tumor aerobic glycolysis**:
- By measuring the extracellular acidification rate (ECAR) and the oxygen consumption rate (OCR), the researchers found that over - expression of FOXM1D can significantly increase ECAR and decrease OCR, which reflects that FOXM1D promotes aerobic glycolysis.
- Conversely, knocking down FOXM1D leads to a decrease in ECAR and an increase in OCR.

3. **FOXM1D inhibits the activity of PKM2 by forming a hetero - octamer**:
- The researchers found through cross - linking experiments and gel - filtration chromatography techniques that after binding to PKM2, FOXM1D can form a hetero - octamer complex, and this complex significantly reduces the enzymatic activity of PKM2.
- The existence of this hetero - octamer explains why FOXM1D can inhibit the metabolic activity of PKM2, thereby promoting aerobic glycolysis.

4. **FOXM1D promotes the transcription and secretion of VEGFA**:
- The researchers found that FOXM1D can promote the nuclear translocation of PKM2 and NF - κB and enhance the transcription of VEGFA.
- The increased VEGFA is secreted extracellularly through the exosome pathway, further promoting tumor angiogenesis.

### Conclusion
This study reveals the mechanism by which FOXM1D promotes aerobic glycolysis and tumor angiogenesis by interacting with PKM2 to form a hetero - octamer complex and inhibiting the metabolic activity of PKM2. This finding provides a new perspective for understanding the regulatory mechanisms of glycolysis and angiogenesis in advanced colorectal cancer and may provide a theoretical basis for the development of new anti - cancer strategies.